국가: 오스트레일리아
언어: 영어
출처: Department of Health (Therapeutic Goods Administration)
tigecycline, Quantity: 50 mg
Accord Healthcare Pty Ltd
Injection, powder for
Excipient Ingredients: maltose; hydrochloric acid; sodium hydroxide
Intravenous
1, 10
(S4) Prescription Only Medicine
TIGECYCLINE INTAS is indicated for the treatment of the following infections in adults:,Complicated skin and skin structure infections, including those with methicillin-resistant Staphylococcus aureus (MRSA), where there is suspected or proven resistance to, intolerance of, or there are co-morbidities preventing the use of, other available agents.,Complicated intra-abdominal infections, where there is suspected or proven resistance to, intolerance of, or there are co-morbidities preventing the use of, other available agents.
Visual Identification: Orange powder or cake; Container Type: Vial; Container Material: Glass Type I Clear; Container Life Time: 24 Months; Container Temperature: Store below 25 degrees Celsius
Registered
2021-02-11